Showing results (221-230 of 296) with videos related to
Sort By:
Pageof 30
The New England Journal of Medicine|April 4, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaMichael Wang, Javier Munoz, Andre Goy, et al.Blood Advances|April 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myelomaJan Hendrik Frenking, Xiang Zhou, Kai Rejeski, et al.Leukemia|October 16, 2023
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphomaMichael Fuchs, Anne Sophie Jacob, Helen Kaul, et al.Nature Communications|January 10, 2026
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extensionPeter Nordbeck, Ozlem Goker-Alpan, John A Bernat, et al.European Journal of Heart Failure|October 24, 2024
Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.JACC. Cardiovascular Interventions|October 17, 2024
Prognostic Impact of Admission Time in Infarct-Related Cardiogenic Shock: An ECLS-SHOCK SubstudyTobias Schupp, Holger Thiele, Tienush Rassaf, et al.European Heart Journal. Acute Cardiovascular Care|March 5, 2025
Femoral versus Radial Approach for Primary Percutaneous Intervention in Cardiogenic Shock: A Subanalysis from the ECLS-SHOCK TrialMohammad Abumayyaleh, Holger Thiele, Tienush Rassaf, et al.European Heart Journal. Acute Cardiovascular Care|January 9, 2025
C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trialTobias Schupp, Holger Thiele, Tienush Rassaf, et al.Clinical Pharmacology and Therapeutics|March 22, 2020
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)Malte Lenders, Peter Nordbeck, Christine Kurschat, et al.Journal of Cardiac Failure|March 5, 2026
Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock - a Secondary Analysis of the DanGer Shock TrialElric Zweck, Rasmus P Beske, Christian Hassager, et al.Pageof 30